Streptococcus pyogenes causes a wide variety of human diseases and is a significant cause of morbidity and mortality. Attempts to develop a vaccine were hampered by genetic diversity of S. pyogenes across different regions of the world.
Introduction
Streptococcus pyogenes (group A streptococcus, GAS) is exclusively a human pathogen and the etiological agent of a wide variety of diseases that vary in clinical severity, while also being a significant cause of morbidity and mortality . These diseases include pharyngitis, impetigo, scarlet fever, post-streptococcal glomerulonephritis, invasive diseases, rheumatic fever (RF) and rheumatic heart disease (RHD) . While rheumatic fever and rheumatic heart disease are the greatest cause of mortality in developing nations, deaths in developed nations are mainly attributable to invasive diseases .
The differences in the prevalence and molecular epidemiology of GAS isolates reflect the differences in the importance of RF/RHD and invasive diseases in these populations. GAS carriage and infection are prevalent in many developing nations, with a large number of different emm types circulating at one time, with no one type being dominant. In contrast, a limited number of specific emm types are predominant in developed nations, and are often associated with specific clinical manifestations .
Despite the majority of GAS associated deaths occurring in developing nations, the majority of comparative genetic and genomic studies have focussed on isolates from developed nations . These studies report a high degree of genetic diversity between isolates with divergent emm types, as well as diversity within an emm type. In regions with high streptococcal disease burden, where GAS isolates are more likely to come into direct contact, the probability of lateral gene transfer (LGT) is increased. Greater inter-and intra-emm-type genetic diversity is likely to exist. Such diversity and potential changes in population structure are important considerations when designing vaccine candidates that should provide coverage against the entire GAS population.
In this study, we used a two step approach in order to identify promising candidates for a region-specific vaccine. In the first step we conducted epidemiological analysis in order to identify antigens conserved in different parts of India, in the second step we purified these antigens and performed serological analysis using convalescent serum samples. We used virulence gene profiling to assess genetic diversity and population structure of GAS in India, a country where streptococcal disease burden is high . We found a high degree of genetic diversity between isolates of different emm types, but relatively conserved genotypes within an emm type. We assessed the distribution of seven genes conserved in Indian isolates encoding current vaccine targets in this population, and report on serological responses against each of these antigens. Vellore (South India), which are about 3000 km apart, have high streptococcal disease burden and different climatic conditions. Besides hospital patients, 3000 and 2400 school children were screened in Chandigarh and Vellore, respectively. Sixtyfive isolates from Chandigarh and 136 from Vellore were included in this study. The isolates were also classified on the basis of recovery from the throat of asymptomatic carriers (n=44), or patients presenting with pharyngitis (n=20). Another 32 isolates were collected from the skin in these surveys. Thirty-four isolates were collected from patients presenting with invasive disease at clinics in Chandigarh and Vellore. The isolation site of 71 isolates was unknown. Serum samples were collected from individuals in North (n=110) and South India (n=75). Eighty-two of these samples were obtained from patients with RHD, 24 collected from patients with RF and 9
sourced from patients with invasive disease. Another 15 were obtained from patients presenting with symptoms of pharyngitis, 30 were asymptomatic patients positive for GAS and 25 sourced from healthy people from the survey areas with no current signs of streptococcal infection. Because of the possibility of subclinical exposure in the survey areas due to high disease burden, we included 10 serum samples collected from healthy people from Germany as controls. The serum samples and streptococcal isolates were from the same patients in case of invasive diseases. For all other clinical manifestations the isolates and serum samples were from the defined survey areas, but not from the same patients.
DNA extraction and emm typing
Genomic DNA was isolated using zirconium beads in combination with the Qiagen DNeasy kit (Qiagen, Hilden, Germany 
Microarray, hybridization and data analysis
The microarray used is this study has been described in detail in a previous study .
Sample preparation, array hybridization and data processing were performed as described previously . Briefly, isolated genomic DNA was digested with AluI, labelled with biotin/streptavidin-Cy5 and fluorescence signals were quantified after hybridization using ImaGene software (BioDiscovery). A two component mixture model was fitted to the background-corrected and log2-transformed data by a maximum likelihood method. A discriminant function was used to represent the propensity of a gene for being present or absent in a particular isolate. Discriminant values were stored in a signal probability matrix and used to construct dendrograms using Bayesian agglomerative hierarchical clustering . All routines for statistical calculations were implemented in the R statistics package (www.r-project.org). 
Results

emm sequence type distribution of GAS isolates from North and South India
The 201 isolates collected represent 69 different emm sequence types (Supplementary Table S1 ) and 83 different emm sequence subtypes (data not shown). The 20 most prevalent emm types ( Figure 1 ) were emm12 (6.5%), emm11
emm44, emm75 and emm112 (2.5% each). The types emm2, emm22, emm69, emm74, emm77, emm93, emm110, emm104 and emm108 accounted for 2% of all strains recovered. The 20 prevalent emm types represented 57.7% of all GAS isolated in both regions.
Of these twenty prevalent emm types, ten (emm4, emm11, emm12, emm44, emm49, emm74, emm80, emm110, emm112, and st1389) were found both in Northern and Southern India. Emm3, emm28, emm69, emm77, emm93, emm104, and emm108
were only found in Southern India, whereas emm2, emm22 emm75 were specific for 
Overview of gene distribution in Indian Isolates
Of the 219 streptococcal virulence factors and extracellular surface proteins (VF/ECP) represented on the array, 91 (41.5%) were found in all isolates (Supplementary Table S2 ), and 150 (68.5%) were found in more than 80% of the isolates. When we analyzed the distribution of the VF/ECP genes with respect to geographic region, 102 genes (46.6%) and 100 genes (45.7%) were present in all North Indian and South Indian isolates, respectively. In order to identify regionspecific virulence genes we statistically analyzed the distribution of VF/ECP genes in both regions. We identified one gene in the North Indian isolates and 15 genes in the South Indian isolates with a statistically significant difference in distribution (Fisher exact test, P < 0.05, Table 2 ), reflecting the higher emm type heterogeneity in South India. However, none of the 16 genes was found exclusively in one of the regions.
Genetic relationships amongst isolates
Emm typing is still largely accepted as sufficient for defining related strains in GAS research. However, epidemiological and molecular observations also demonstrate that LGT involving the emm gene occurs, suggesting that isolates of the same emm type that are temporally or geographically displaced may be genetically diverse, and be more closely related to isolates of a different emm type . To investigate the relationship between all isolates we used a Bayesian agglomerative hierarchical cluster algorithm (BHC) to construct a dendrogram of all isolates that were represented by ≥ 3 isolates per emm type (n = 154 isolates), based on the presence or absence of all genes represented on the array. Using this approach we found isolates of the same emm type to predominantly cluster together ( Figure 2 ).
However, there were instances where this did not occur, suggesting that LGT of the emm gene may have occurred in these instances. We next analyzed the association of the clusters with regard to disease type. As shown in Fig 2, there was only one distinct sub-cluster solely composed of invasive isolates consisting of one emm4, one emm28 and three emm49 strains. Using BHC clustering we did not find any significant clustering of virulence factors with invasive and non-invasive isolates.
However, when we analyzed the association of virulence factors with invasiveness using the Fischer´s Exact Test (P<0.05), we found 13 genes positively associated with invasiveness (Supplementary Table S3 ). Six genes were negatively associated with invasiveness (odds ratio < 1).
Serological response to vaccine antigens
We examined the distribution of the shortlisted seven GAS vaccine candidates in the India population, and found them to be highly conserved across the population (Table   3 ). Collagen-like surface protein (SCl), putative secreted 5'nucleotidase (PSNT) and C5a peptidase were found in 100% of isolates. R28, the putative surface antigen (PSA) and the hypothetical protein (HYP) were found in more than 90% of isolates.
Streptococcal fibronectin-binding protein I (SfbI) was found in 78.5% of isolates.
Serum antibodies indicate that epitopes of a particular protein are visible to the host immune system, and these proteins are likely to be recognized by antibodies generated against corresponding vaccine candidates. Therefore, we next investigated serological responses to these seven identified GAS vaccine candidates. We expressed these proteins as fusion with GST and used them in ELISA with human sera (Figure 3 ). Control healthy sera had very low immune response against all of the proteins. The majority of serum samples from India had elevated responses to PSNT, C5a peptidase and PSA, demonstrating the high incidence of GAS infection in these populations. PSA-specific IgG responses were statistically more frequent in the pharyngitis group than in healthy and RHD groups (P < 0.05). Lower antigen specific antibody responses were observed with HYP and SfbI. For these two proteins the highest responses were observed with sera collected from pharyngitis patients and patients with GAS throat colonization at the time of sera collection. For HYP, IgG responses in the pharyngitis group were statistically significantly higher than the healthy from non-survey and survey areas and RF groups (P < 0.05). The SfbI response for both the carrier group and pharyngitis group was statistically significantly higher than control and RHD groups (P < 0.05) (Supplementary Table   S4 ). The majority of sera did not respond, or responded weakly to R28 and SCl. No differences in responses were observed in sera collected from North and South India.
For 4/7 of the proteins used here the response in pharyngitis sera was significantly higher than non-survey area healthy sera (Supplementary Table S4 ) indicating the possibility that these proteins are most likely expressed in the early phase of infection.
Discussion
This study is the most comprehensive assessment of the genetic repertoire of GAS carried out in a country with high streptococcal disease burden. The twenty most common emm types accounted for 57.7% of the isolates collected, reinforcing the high degree of diversity in the population based on emm typing and is consistent with results of other studies of GAS population structure carried out in developing nations . Within the Indian population, 91 genes were conserved in 100% of isolates.
Using the same array, we previously reported that 129 and 125 genes were 100% conserved in GAS isolates from the Netherlands and United States respectively. The majority (80 genes) of conserved genes in the isolates from Europe and India were similar, indicating that they are part of the GAS core genome and encode proteins that are critical for virulence or confer biological functions essential to the fitness of the organism, and are therefore promising vaccine candidates.
The M-protein remains a favored GAS vaccine candidate. The predominant bactericidal antibody response raised after GAS infection targets the amino-terminal of the M-protein, the same region that is used for emm-typing. However antibodies raised against this region have traditionally been thought to be type specific i.e. The seven proteins we examined serologically have all been proposed as potential vaccine candidates, and were chosen here because they represent both well characterized and relatively new targets. All these proteins are also predicted to be surface associated. Our array data support this selection because six of these proteins were conserved in all of the invasive isolates tested in this study. R28 is a cell surface virulence protein which has many repetitive sequence and has homology with a protein found in group B streptococcus . SCI is a collagen like protein which is known to have collagen like sequence . HYP has homology with FbaA proteins , suggesting it to have fibronectin binding ability. PSNT is a putative surface nucleotidase protein likely to be involved in nutrient acquisition . The corresponding PNST of Haemophillus influenzae has been reported to have protective efficacy in a rat infection model . PSA is a homologue to spy0843 of S. pyogenes MGAS5005 which contributed to a protective host immune response in a mouse infection model .
The identified antigens were validated for their vaccine potential by serological analysis. For invasive disease we had the matching isolates and serum samples, because these were acute manifestations that required hospitalization. For other manifestations, which were not acute, it was not possible to have the matching isolate serum samples, so we had to rely on the samples from defined survey areas.
The immunogenicity of the identified proteins were tested using ELISA in order to determine their suitability as vaccine candidates. For simplicity, antibodies were determined using a single dilution and results were expressed as OD values. For further studies on these antigens, however, the end point titers or the use of a reference standard serum will be required . Our data demonstrates that antibodies to five of the seven GAS proteins are present in sera in individuals living in a region where streptococcal disease is common. In general, there was no difference between antibody levels between individuals, irrespective of disease status of individuals.
However two proteins, HYP and SfbI, had higher antibody responses in sera from pharyngitis and asymptomatic throat carriers when compared to sera from RF/RHD and asymptomatic non-carriers. Fibronectin binding proteins have been shown to be involved in adherence to epithelial cells and may therefore be important in colonization and early infection. Responses to PSA, which binds to the surface of epithelial cells were also significantly higher in sera from pharyngitis patients. Given the increased antibody response to these three antigens (HYP, SfbI and PSA) in carriers and patients with pharyngitis, they may be excellent candidates for inclusion in a vaccine designed to prevent initial colonization. In this study, generally a lower immune response was detected against all the proteins with serum samples from invasive diseases. This could be due to the fact that the invasive disease is an acute manifestation where the time is too short for the generation of sufficient antibodies to
give a high response.
In conclusion, PSNT, C5a peptidase, PSA, HYP and SfbI are promising candidates for a region-specific streptococcal vaccine for the Indian continent. Among these five candidates PSA and PSNT are not well studied and can be further explored in future studies. The two-step approach used in this study to identify vaccine candidates with regional specificity seems to be very promising. However, more isolates and more defined serum samples should be analyzed in further work to support this study.
Acknowledgments
The authors would like to thank N. Janze for excellent technical assistance. This work Version 2012/09/05 gsc Version 2012/09/05 gsc 
